ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610173; 2) Community: the network communities that were significantly associated with the response to NSC 610173; 3) Molecule: the relationships between components within communities and NSC 610173; 4) MDR: the compounds that were significantly associated with the NSC 610173.

NSC Compound Enrichment Correlation
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.00578566967432525 -0.075450928
NSC 685865 Null 0.00578566967432525 0.52367317
NSC 697715 Null 0.00578566967432525 0.50647185
NSC 731527 cyanoaminopyranopyridine derivatives 0.00578566967432525 0.20770522
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00578566967432525 0.55042818
NSC 174121 Methotrexate Derivative 0.00578566967432527 -0.2394213
NSC 30637 Null 0.00578566967432527 -0.18340805
NSC 610459 Camptothecin Derivative 0.00645628049634952 0.12342751
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.00645628049634952 -0.17876415
NSC 629736 Null 0.00645628049634952 -0.16968327
Total:111  Current:21    [First] [Prev] [Next] [Last]